References
- Suchina J, Lüthi-Corridori G, Jaun F, Leuppi JD, Boesing M. Diagnosis and Treatment of Acute Heart Failure: A Retrospective Observational Study and Medical Audit. Journal of Clinical Medicine. 2024;13(19):5951.
- Abd Alredha RD, Farman HA. Plasma L-FABP as a superior biomarker for detecting and characterizing cardiorenal syndrome in acute heart failure: comparative insights with hs-troponin T and NT-proBNP. Anaesthesia, Pain & Intensive Care. 2025;29(2):284-293.
- Tanwar P, Naagar M, Malik G, et al. Relationship between right heart failure and cardio-renal syndrome: A review. 2023.
- Desai R, Damarlapally N, Bareja S, et al. A systematic review and meta-analysis evaluating the association of high sensitivity troponin levels with outcomes in patients with stable coronary artery disease. Current Medical Research and Opinion. 2024;40(10):1685-1695.
- Rosół N, Procyk G, Kacperczyk-Bartnik J, Grabowski M, Gąsecka A. N-terminal prohormone of brain natriuretic peptide in gestational hypertension and preeclampsia–State of the art. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2024;
- Christodorescu RM, Brie DM, Brie AD, et al. Clinical and Demographic Characteristics of Patients Hospitalized for Decompensated Heart Failure with Extremely High NT-proBNP Levels. Diagnostics. 2024;14(22):2507.
- Faraj HR. Serum NT-pro BNP and Other Biochemical Markers in Patients with Cardiorenal Syndrome (CRS) in Thi-Qar province-Iraq. Journal of Bioscience and Applied Research. 2024;10(4):686-694.
- Gürgöze MT, Van Vark LC, Baart SJ, et al. Multimarker analysis of serially measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, creatinine, and prognosis in acute heart failure. Circulation: Heart Failure. 2023;16(1):e009526.
- Koechlin L, Boeddinghaus J, Lopez-Ayala P, et al. Performance of high-sensitivity cardiac troponin T versus I for the early diagnosis of myocardial infarction. European Heart Journal. 2022;43(Supplement_2):ehac544. 1339.
- Segre CAW, De Lemos JA, Junior ANA, et al. Chronic troponin elevation assessed by myocardial T1 mapping in patients with stable coronary artery disease. Medicine. 2023;102(16):e33548.
- Chaulin AM. The importance of cardiac troponin metabolism in the laboratory diagnosis of myocardial infarction (comprehensive review). BioMed Research International. 2022;2022(1):6454467.
- Maayah M, Grubman S, Allen S, et al. Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing. Diagnostics. 2024;14(5):503.
- Chaikijurajai T, Demirjian S, Tang WW. Prognostic Value of Natriuretic Peptide Levels for Adverse Renal Outcomes in Patients With Moderate to Severe Acute Kidney Injury With or Without Heart Failure. Journal of the American Heart Association. 2023;12(21):e031453.
- Idris I. Four biomarkers shown to predict the risk of progressive heart and kidney disease in people with type 2 diabetes with diabetic kidney disease. Wiley Online Library; 2023.
- Kula A, Bansal N. Applications of cardiac biomarkers in chronic kidney disease. Current opinion in nephrology and hypertension. 2022;31(6):534-540. d
- Zhang S, Wang Y, Song D, et al. Nanopore discrimination and sensitive plasma detection of multiple natriuretic peptides: The representative biomarker of human heart failure. Biosensors and Bioelectronics. 2023;231:115299.
- Roos A, Edgren G, Holzmann MJ. Temporal Changes of Stable High-Sensitivity Cardiac Troponin T Levels and Prognosis. Journal of the American Heart Association. 2022;11(11):e025082.
- Penda S, DZUDIE A, Fouda H, Ebene R, Halle MP. NT-proBNP: A Potential Diagnostic Tool for Left Ventricular Hypertrophy in Patients with Chronic Kidney Disease in a Tertiary Hospital In Sub-Saharan Africa. Circulation. 2024;150(Suppl_1):A4146586-A4146586.
- Neuen B, Vaduganathan M, Claggett B, et al. Natriuretic peptides, kidney function and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction: pooled data from the I-PRESERVE, TOPCAT, PARAGON and DELIVER trials. European Heart Journal. 2024;45(Supplement_1):ehae666. 786.
- Run-Qing J, Bin W, Zhang J-G, et al. Independent prognostic value of the congestion and renal index in patients with acute heart failure. Journal of Geriatric Cardiology: JGC. 2023;20(7):516.
- Carubelli V, Metra M, Lombardi C, et al. Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. Heart failure reviews. 2012;17:271-282.
- Mitsas AC, Elzawawi M, Mavrogeni S, et al. Heart failure and cardiorenal syndrome: a narrative review on pathophysiology, diagnostic and therapeutic regimens—from a cardiologist’s view. Journal of Clinical Medicine. 2022;11(23):7041.
- Baumgartner H, De Backer J. The ESC clinical practice guidelines for the management of adult congenital heart disease 2020. Oxford University Press; 2020.
- Aletras G, Stratinaki M, Eleftheriadou E, et al. Acute cardiorenal syndrome: baseline comorbidities, biomarkers and prognostic significance. European Journal of Preventive Cardiology. 2024;31(Supplement_1):zwae175.043.
- McCallum W, Sarnak MJ. Cardiorenal syndrome in the hospital. Clinical Journal of the American Society of Nephrology. 2023;18(7):933-945.
- Shrestha B, Dunn L. The declaration of Helsinki on medical research involving human subjects: a review of seventh revision. 2019.
- Inker LA, Eneanya ND, Coresh J, et al. New creatinine-and cystatin C– based equations to estimate GFR without race. New England Journal of Medicine. 2021;385(19):1737-1749.
- Markovic M, Kragholm K, Torp-Pedersen C, Pareek M. High-sensitivity troponin T and risk of stroke in persons with suspected acute coronary syndrome. European Heart Journal. 2024;45(Supplement_1):ehae666. 1607.
- Hammerer-Lercher A, Maria B, Wussler D, et al. A-018 Diagnostic Performance of the Novel Beckman-Coulter NT-proBNP-assay in the Early Diagnosis of Acute Heart Failure. Clinical Chemistry. 2024;70(Supplement_1):hvae106. 018.
- Zydzik L, Dadanski E, Tyjas K, et al. Comparison of left ventricular volumes and ejection fraction values between echocardiography and cardiac magnetic resonance: a pilot study. Journal of Hypertension. 2024;42(Suppl 1):e147.
- George D, Mallery P. IBM SPSS statistics 26 step by step: A simple guide and reference. Routledge; 2019.
- Shende P, Reddy A, Vikhe VB, Patil RS, Faruqi AA, Khandol D. A Study of Abnormal Echocardiogram Findings in Patients With Chronic Kidney Disease With Reference to Cardiac Biomarkers. Cureus. 2024;16(7):e65398.
- Landler NE, Olsen FJ, Christensen J, et al. Associations between albuminuria, estimated GFR and cardiac phenotype in a cohort with chronic kidney disease: the CPH-CKD ECHO study. Journal of Cardiac Failure. 2022;28(11):1615-1627.
- Sobue Y, Watanabe E, Funato Y, Yanase M, Izawa H. Renal dysfunction is a time-varying risk predictor of sudden cardiac death in heart failure. ESC Heart Failure. 2024;
- Horiuchi Y, Wettersten N, van Veldhuisen DJ, et al. Potential utility of cardiorenal biomarkers for prediction and prognostication of worsening renal function in acute heart failure. Journal of cardiac failure. 2021;27(5):533-541.
- Sciaccaluga C, Ghionzoli N, Mandoli GE, et al. Biomarkers in patients with left ventricular assist device: An insight on current evidence. Biomolecules. 2022;12(2):334.
- Chen R, Pang M, Yu H, et al. Kidney function–specific cut-off values of high-sensitivity cardiac troponin T for the diagnosis of acute myocardial infarction. Clinical Kidney Journal. 2024;17(9):sfae247.
- Ruocco G, Palazzuoli A, Ter Maaten JM. The role of the kidney in acute and chronic heart failure. Heart failure reviews. 2020;25:107-118.
- da Costa T, da Costa Machado E, de Barros LAAC, et al. Heart Failure and Chronic Kidney Disease: Prognosis and Therapeutic and Surgical Options. Brazilian Journal of Implantology and Health Sciences. 2024;6(8):1119-1132.
- Kristensen JH, Hasselbalch RB, Strandkjær N, et al. Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans. Circulation. 2024;150(15):1187-1198.
- Choi Y, Lee JH. Clinical usefulness of NT-proBNP as a prognostic factor for septic shock patients presenting to the emergency department. Scientific Reports. 2024;14(1):10999.
- Dri E, Lampas E, Lazaros G, et al. Inflammatory mediators of endothelial dysfunction. Life. 2023;13(6):1420.
- Song J-S, Cao C, Li H-R, Li L, Liu J-X. Mechanisms of oxidative stress in myocardial ischemia-reperfusion injury and protective effects of traditional Chinese medicines. Zhongguo Zhong yao za zhi= Zhongguo Zhongyao Zazhi= China Journal of Chinese Materia Medica. 2024;49(13):3452-3461.
- Zhao X, Han D, Zhao C, et al. New insights into the role of Klotho in inflammation and fibrosis: molecular and cellular mechanisms. Frontiers in Immunology. 2024;15:1454142.
- Akhabue E, Wong M, Mehta R, et al. Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study. American heart journal. 2022;245:10-18.
- Frangogiannis NG. TGF-β as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities. Expert Opinion on Therapeutic Targets. 2024;28(1-2):45-56.
- Jackson JW, Streich Jr FC, Pal A, et al. An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis. Science Signaling. 2024;17(844):eadn6052.